Apoptosis of cultured neuroblastoma cells is induced by ceramide and not by ligation of the Fas/Apo-1/CD95 receptor

Chemotherapy

Volumn 45, Issue 4, 1999, Pages 258-267

  Barthlen, Winfried ^a   Schäfer, Jochen ^a   Girgert, Rainer ^a   Schuster, Monika ^a   Schweizer, Paul ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Apoptosis; Ceramide; Fas Apo 1 CD95 receptor; Neuroblastoma

Indexed keywords

CERAMIDE; FAS ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROPIDIUM IODIDE;

APOPTOSIS; ARTICLE; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

ANTIGENS, CD95; APOPTOSIS; CERAMIDES; HUMANS; INFANT; LIGANDS; NEUROBLASTOMA; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0033004785     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007195     Document Type: Article

References (53)

1. Iwata M, Koshinaga T, Okabe I, Kurosu Y, Esumi M: Biological characteristics of neuroblastoma with spontaneous tumor reduction: A case report. J Pediatr Surg 1995;30: 722-723.
2. Ikeda H, Hirato J, Akami M, Suzuki N, Takahashi A, Kuroiwa M, Matsuyama S: Massive apoptosis detected by in situ DNA nick end labeling in neuroblastoma. Am J Surg Pathol 1996;20:649-655.
3. Lowe SW, Ruley HE, Jacks T, Housman DE: p53 dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-967.
4. Möröy T, Zörnig M: Regulators of life and death: The bcl-2 gene family. Cell Physiol Biochem 1996;6: 321-336.
5. Nagata S, Goldstein P: The Fas death factor. Science 1995;267: 1449-1456.
6. Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV: A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993;74:845-853.
7. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1 associated protein TRADD signals cell death and NF-κB activation. Cell 1995;81:495-504.
8. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain containing protein interacts with the death domain of Fas and initiates apoptosis. Cell 1995; 81:505-512.
9. Stanger BZ, Leder P, Lee TH, Kim E, Seed B: RIP: A novel protein containing a death domain that interacts with Fas/Apo-1 (Cd 95) in yeast and causes cell death. Cell 1995;81: 513-523.
10. Muzio M, Chinnaiyan AM, Kischkel F, O'Rourke K, Shevchenko A, Scaffidi C, Bretz JD, Zhang M, Ni J, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: FLICE, a novel FADD homologous ICE/CED-3-like protease, is recruited to the CD 95 (Fas/Apo-1) death-inducing complex. Cell 1996;85:817-827.
11. Boldin MP, Goncharov TM, Goltsev YV, Wallach D: Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/Apo-1 and TNF receptor-induced cell death. Cell 1996;85:803-815.
12. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992;148:1274-1279.
13. Singer GG, Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994;1:365-371.
14. Suda T, Takahashi T, Goldstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-1178.
15. Schlottmann K, Coggeshall KM: CD95/Fas/Apo-1 mediated signal transduction. Cell Physiol Biochem 1996;6:345-360.
16. Suda T, Nagata S: Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994;179:873-879.
17. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Brummond AH, Nagata S: Fas ligand in human serum. Nat Med 1996;2:317-322.
18. Bhandoola A, Yui K, Siegel RM, Zerva L, Greene MI: Gld and Ipr mice: Single gene mutant models for failed self tolerance. Int Rev Immunol 1994;11:231-244.
19. Watanabe-Fukunaga R, Brannan CL, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-317.
20. Martin SJ, Green DR: Protease activation during apoptosis: Death by a thousand cuts? Cell 1995;82:349-352.
21. Kränke M, Schütze S, Wiegmann K, Machleidt T: Shingomyelinases and TNF-induced apoptosis. Cell Physiol Biochem 1996;6:337-344.
22. Yao B, Zhang Y, Delikat S, Mathias S, Basu S, Kolesnick R: Phosphorylation of Raf by ceramide-activated protein kinase. Nature 1995;378: 307-310.
23. Lozano J, Berra E, Municio MM, Diaz-Meco MT, Dominguez I, Sanz L, Moscat J: Protein kinase C isoform is critical for kappa B-dependent promoter activation by sphingomyelinase.J Biol Chem 1994;269: 19200-19202.
24. Joseph CK, Byun HS, Bittman R, Kolesnick RN: Substrate recognition by ceramide-activated protein kinase. J Biol Chem 1993;268: 20002-20006.
25. Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman A, Green D: Fas-induced apoptosis is mediated via a ceramide-initiated Ras signaling pathway. Immunity 1995;2:341-351.
26. Verheij M, Bose R, Lin XH, Yao B, Grant S, Birrer MJ, Szabo E, On LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN: Requirement for ceramide-initiated SAPK/ JNK signalling in stress-induced apoptosis. Nature 1996;380:75-79.
27. Ponton A, Clement MV, Stamenkovic I: The CD95 (APO-1/Fas) receptor activates NF-κB independently of its cytotoxic function. J Biol Chem 1996;271:8991-8995.
28. Pronk GJ, Ramer K, Amiri P, Williams LT: Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 1996;271:808-810.
29. Susin SA, Zamzami N, Castedo M, Daugas E, Wang HG, Geley S, Fassy F, Reed JC, Kroemer G: The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/ APO-1/CD95-and ceramide-induced apoptosis. J Exp Med 1997; 186:25-37.
30. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere PX, Kroemer G: Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 1995; 181:1661-1672.
31. Kluck R, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cytochrome c from mitochondria: A primary site for bcl-2 regulation of apoptosis. Science 1997;275:1132-1136.
32. Yang J, Lui X, Bhalla K, Kim NC, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X: Prevention of apoptosis by bcl-s: Release of cytochrome c from mitochondria blocked, Science 1997;275:1129-1132.
33. Rudolph G, Schilbach-Stuckle K, Handgretinger R, Kaiser P, Hameister H: Cytogenetic and molecular characterization of a newly established neuroblastoma cell line LS. Hum Genet 1991;86:562-566.
34. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-279.
35. Owen-Schaub LB, Radinsky R, Kruzel E, Berry K, Yonehara S: Anti-Fas on nonhematopoietic tumors: Levels of Fas/Apo-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res 1994;54:1580-1586.
36. Aggarwal BB, Singh S, LaPushin R, Totpal K: Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS Lett 1995;36:5-8.
37. Mapara MY, Bargou R, Zugk C, Döhner H, Ustaoglu F, Jonker RR, Krammer PH, Dörken B: Apo-1 mediates apoptosis or proliferation in human chronic B lymphocytic leukemia: Correlation with bcl-2 oncogene expression. Eur J Immunol 1993;23:702-708.
38. Richardson BC, Lalwani ND, Johnson KJ, Marks RM: Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol 1994;24:2640-2645.
39. Debatin KM, Krammer PH: Resistance to APO-1(CD95) induced apoptosis in T-ALL is determined by a bcl-2 independent anti-apoptotic program. Leukemia 1995;9:815-820.
40. Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM: The CD95 (Apo-1/ Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 1997;57:3823-3829.
41. Friesen C, Fulda S, Debatin KM: Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells. Leukemia 1997;11:1833-1841.
42. Cascino I, Papoff G, De Maria R, Testi R, Ruberti G: Fas/Apo-1(CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. J Immunol 1996;156:13-17.
43. Kikuchi H, Sugiyama S, Imajoh-Ohmi S: A novel anti-apoptosis serum factor that down-regulates fas-mediated apoptosis. J Biochem 1995;117:936-939.
44. Los M, Herr I, Friesen C, Fulda S, Schulze-Osthoff K, Debatin KM: Cross-resistance of CD95 and drug induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases). Blood 1997; 90:3118-3129.
45. Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nunez G, Krammer PH, Peter ME, Debatin KM: Betulinic acid triggers CD95 (Apo-1/Fas) and p53 independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res 1997;57:4956-4964.
46. Peter ME, Kischkel FC, Scheuerpflug CG, Medema JP, Debatin KM, Krammer PH: Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur J Immunol 1998;27: 1207-1212.
47. Brenner B, Ferlinz K, Grassme H, Weller M, Koppenhoefer U, Dichgans J, Sandhoff K, Lang F, Gulbins E: Fas/CD95/Apo-1 activates the acid sphingomyelinase via caspases. Cell Death Differ 1998;5:29-37.
48. Bose R, Verheij M, Haimovitz-Friedman A, Scuotto K, Fuks Z, Kolesnick R: Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 1995; 82:405-414.
49. Weller M, Frei K, Groscurth P, Klammer PH, Yonekaea Y, Fontana A: Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells - Induction and modulation of sensitivity by cytokines. J Clin Invest 1994;94:954-964.
50. Zamzami N, Susin S, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, Kroemer G: Mitochondrial control of nuclear apoptosis. J Exp Med 1996;183:1533-1544.
51. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M, Kroemer G: Bcl-2 inhibits the mitochondrial release of an apoptotic protease. J Exp Med 1996;184:1331-1341.
52. Enari M, Talanian RV, Wong WW, Nagata S: Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 1996;380:723-726.
53. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME: Two CD95 (Apo-1/Fas) signaling pathways. EMBO J 1998;17:1675-1687.